MGDs are not a new concept – established blood cancer drugs Bristol-Myers ... San Diego, California-based Neomorph was set up in 2020 by investment group Deerfield Management, coming out of ...
In the case of its heart failure candidate CDR132L, that includes addressing the diminished contractility and overgrowth of heart muscle, fibrosis (scarring), and the formation of new blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback